CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Director Shareholding

13/07/2004 7:13pm

UK Regulatory

RNS Number:8160A
Celsis International PLC
13 July 2004


Celsis International PLC

Directors' Shareholdings


Celsis International plc has been notified that Jay LeCoque, Chief Executive
Officer and Christian Madrolle, Finance Director, have each acquired 50,000
shares at 32p.  Accordingly, their total holdings are now 550,000 and 400,000
shares respectively, representing 0.49% and 0.36% of the issued share capital.

                                                                    13 July 2004

Enquiries:

Celsis International plc                                    Tel: 01638 600 151

Jay LeCoque, Chief Executive Officer
Jenny Parsons, Corporate Communications

College Hill                                                Tel: 020 7457 2020

Nicholas Nelson
Corinna Dorward



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSUOAWRSARBAAR